Add-On Fruquintinib Delays Progression in Gastric Cancer

Please enable cookies.

Error
1005

Ray ID: 8751a9278b206ed1 •
2024-04-16 05:09:00 UTC

What happened?

The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website.

Was this page helpful?

Thank you for your feedback!

Cloudflare Ray ID: 8751a9278b206ed1

Your IP:

185.124.111.116


Performance & security by Cloudflare

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Chicago firm partners with CommonWell to tackle health disparities via data exchange thumbnail

Chicago firm partners with CommonWell to tackle health disparities via data exchange

CareAdvisors, a Chicago-based health technology firm, introduced what it's calling an "equity information exchange" this past week, aimed at enabling network partners to share medical and social data about vulnerable patients.   The EIX provides access to more than 150 million patient records nationwide via the Commonwell Health Alliance.   "With an EIX, patients and…
Read More
Zurich health director Rickli promises: By the beginning of February, everyone who wants will be boosted - the most important questions and answers about vaccination thumbnail

Zurich health director Rickli promises: By the beginning of February, everyone who wants will be boosted – the most important questions and answers about vaccination

In Zürich sind 511 000 Drittimpfungen verabreicht worden. Seit 1. Januar gilt die vom Bund empfohlene Frist von vier Monaten. Eine Übersicht. Seit dem 3. Januar können Kinder zwischen 5 und 11 Jahren im Kanton Zürich für die Impfung angemeldet werden. Emily Elconin / Bloomberg Alle weiteren Nachrichten zum Coronavirus in der Schweiz finden Sie in unserer Übersicht.…
Read More
Vaccine expected to induce strong immune responses against 2022 monkeypox virus, research shows thumbnail

Vaccine expected to induce strong immune responses against 2022 monkeypox virus, research shows

The figure shows that, for two example proteins that are targeted by VACV-vaccine-induced antibodies, the 2022 monkeypox virus (MPXV-2022) does not comprise any new mutations relative to the previously observed monkeypox virus (MPXV-CB). Credit: HKUST & UoM New research has suggested that recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the
Read More
Index Of News
Total
0
Share